CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


11-February-2014
New from Cerilliant - Certified Spiking Solution® of the anticonvulsant internal standard, Pregabalin-13C6 at a concentration of 100 µg/mL in Methanol.

Pregabalin-13C3, 100 ug/mL, P-106
100 µg/mL in Methanol

Sold under the trade name Lyrica®, pregabalin is an anticonvulsant/antiepileptic drug used for treatment of seizures, fibromyalgia, diabetic peripheral neuropathy, generalized anxiety disorder, and chronic neuropathic pain. This internal standard is suitable for quantitation of pregabalin levels in urine, serum, or plasma by GC/MS or LC/MS for urine drug testing, clinical toxicology, or forensic analysis.

Coming soon, Cerilliant will introduce the following anticonvulsants/antiepileptics internal standards:
 
10,11-Dihydro-10-Hydroxycarbamazepine-13C6  (D-104)
Oxcarbazepine-13C6  (O-039)
Gabapentin-13C3 (G-018)



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn